Treatment time | Number of studies reporting positive effects | Total number of studies | Percentage of studies reporting positive effects | Probability of an equal or greater percentage of positive results from an ineffective treatment | Random effects meta-analysis results |
Early treatment | 24 | 27 | 88.9% | 1 in 41 thousand | 72% improvement RR 0.28 [0.18‑0.45] p < 0.0001 |
Late treatment | 20 | 22 | 90.9% | 1 in 17 thousand | 40% improvement RR 0.60 [0.48‑0.76] p < 0.0001 |
Prophylaxis | 14 | 14 | 100% | 1 in 16 thousand | 86% improvement RR 0.14 [0.08‑0.25] p < 0.0001 |
All studies | 58 | 63 | 92.1% | 1 in 1 trillion | 68% improvement RR 0.32 [0.25‑0.40] p < 0.0001 |
Looks like prophylaxis is the way to go. 86% compared to 72% for early treatment. Late treatment = hospital/bad.
I'm going to have to do some reading there, check out some studies. Brett Weintein show I saw said Ivermectin is oil soluble and also said take it with food due to that.
Another one for the “list”
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
American Journal of Therapeutics: July/August 2021 - Volume 28 - Issue 4 - p e434-e460
doi: 10.1097/MJT.0000000000001402